Back to search

Cornell University

FERULIC ACID AS A POTENTIAL THERAPEUTICAL AGENT IN METABOLIC SYNDROME PREVENTION-MOLECULAR MECHANISM OF ACTION

Abstract

dc:description.abstract

Metabolic syndrome (MetS) is a prevalent and multifaceted disorder characterized by the clustering of metabolic abnormalities, including insulin resistance, dyslipidemia, obesity, and chronic inflammation. These interconnected pathologies significantly increase the risk of developing life-threatening conditions like cardiovascular disease, type 2 diabetes, and metabolic dysfunction-associated fatty liver disease (MAFLD). The high prevalence of MetS is largely attributable to the overconsumption of nutrients associated with urban lifestyles. Consequently, there is an urgent need to explore therapeutic strategies addressing dietary interventions that can simultaneously target multiple aspects of MetS. Phenolic compounds, abundant in whole grains and medicinal plants, have garnered significant attention for their potential to combat metabolic diseases due to their antioxidant, anti-inflammatory, and metabolic regulatory properties. Our research aimed to elucidate the therapeutic effects of ferulic acid (FA), a prominent phenolic compound, on various pathological features of MetS using the palmitate-treated HepG2 hepatic cell line as an in vitro model. Our findings demonstrate that FA ameliorates insulin resistance, dyslipidemia, and gluconeogenesis by modulating the insulin/IGF-1 receptor/PI3K/AKT signaling pathway, thereby improving glucose and lipid metabolism. Additionally, FA counteracts mitochondrial dysfunction and impaired autophagy by restoring mitochondrial dynamics and promoting autophagic flux through the AMPK signaling pathway, ensuring cellular homeostasis. Notably, FA also regulates cell cycle progression and inflammation by inhibiting NF-κB signaling, reducing pro-inflammatory cytokine production, and regulating cell cycle-related proteins, thus mitigating palmitate-induced G1 cell cycle arrest and chronic inflammation. These multifaceted effects underscore FA's therapeutic potential in preventing and combating MetS.

Degree

thesis:*
Name thesis:degree_name
Ph. D., Food Science and Technology
Level thesis:degree_level
Doctor of Philosophy
Discipline thesis:degree_discipline
Food Science and Technology
Grantor
Cornell University
Year dc:date.issued
2024

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Li, Yitong
Chair dc:contributor.chair
  • Liu, Rui
Committee members dc:contributor.committeemember
  • Brenna, James
  • Glahn, Raymond

Subjects

dc:subject × 6

Rights

Language dc:language.iso
en

Identifiers

dc:identifier.*
Dc Identifier Bibid
16611716
Dc Identifier Other
ProQuest Submission ID: 14437
ProQuest Publication ID: 31481873

Chain of custody

source
Harvested from
Cornell University
Base URL
ecommons.cornell.edu/server/oai/request
Last updated
2026-11-19
Source record
OAI-PMH GetRecord
citation

Li, Yitong. FERULIC ACID AS A POTENTIAL THERAPEUTICAL AGENT IN METABOLIC SYNDROME PREVENTION-MOLECULAR MECHANISM OF ACTION. Doctor of Philosophy thesis, Cornell University, 2024. https://hdl.handle.net/1813/116507